Malaria Diagnosis & Treatment in the United States

Healthcare providers should always obtain a travel history from febrile patients. Fever in a person who has recently traveled in a malaria-endemic area should always be immediately evaluated using the appropriate diagnostic tests for malaria. Diagnosis Rapid and accurate diagnosis of malaria is integral to the appropriate treatment of affected […]

Read More

Effect of Early Treatment with Ivermectin among Patients with Covid-19

The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear. METHODS We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2–positive adults […]

Read More

Potential New Treatment Option for COVID-related ARDS

New research suggests that alpha-1 antitrypsin could be an effective option for treating those with COVID-related acute respiratory distress syndrome (ARDS). In their study, published in the journal Med, researchers from RCSI University of Medicine and Health Sciences and Beaumont Hospital Dublin investigated the effects of using the anti-inflammatory protein alpha-1 antitrypsin […]

Read More

WHO updates its treatment guidelines to include molnupiravir

This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant WHO has updated its living guidelines on COVID-19 therapeutics to include a conditional recommendation on molnupiravir, a new antiviral medicine. This is the first oral antiviral drug […]

Read More

Convalescent plasma treatment for COVID-19 sees renewed promise in study

Medical researchers say there is renewed promise in reducing COVID-19-related hospitalizations and deaths by increasing the use of convalescent plasma treatments early on in a coronavirus infection. And some medical experts are pushing the federal government to allow more patients to receive the treatment, as lab-based monoclonal treatments such as […]

Read More

Could This Be Our First Effective, Inexpensive, Widely Available Outpatient Treatment for COVID-19?

It’s fluvoxamine. This rarely used antidepressant, long off-patent, has quietly been going through high-quality clinical studies for treatment of COVID-19. It certainly won’t be endorsed or promoted by any deep-pocketed pharmaceutical company, but deserves some attention nonetheless. Here’s why I think we might finally be onto something with this “repurposed” drug, even […]

Read More
Translate »